052907410 | skhs | 50999409 | | 221016 | 10/22/2002 12:00:00 am | chf exacerbation | | dis | admission date: 1/21/2002 report status:discharge date: 10/24/2002 discharge orders gerich , andreas a 935-72-18-7asservice: meddischarge patient on: 9/5/02 at 03:30 pmcontingent upon attending evaluationwill d/c order be used as the d/c summary: yesattending: leischner , kenny brice , m.d.code status:full codedisposition: home w/ servicesdischarge medications:tylenol #3 ( acetaminophen w/codeine 30mg )1-2 tab po q4-6h prn painatenolol 100 mg po qdpremarin ( conjugated estrogens ) 1.25 mg po qdprozac ( fluoxetine hcl ) 20 mg po qidoverride notice: override added on 2/17/02 by whittier , lorenzo g d. on order for hctz po ( ref # 96303640 )potentially serious interaction: fluoxetine hcl &hydrochlorothiazide reason for override: awareprevious override information:override added on 2/17/02 by sieminski , willis g.on order for lasix iv ( ref # 03201159 )potentially serious interaction: fluoxetine hcl &furosemide , inj reason for override: awarehctz ( hydrochlorothiazide ) 12.5 mg po qdalert overridden: override added on 2/17/02 bypenez , domenic b.potentially serious interaction: fluoxetine hcl &hydrochlorothiazide reason for override: awarelisinopril 40 mg po qdalert overridden: override added on 12/10/02 bythesing , lloyd w.potentially serious interaction: potassium chloride &lisinopril reason for override: awareamlodipine 10 mg po qd food/drug interaction instructionavoid grapefruit unless md instructs otherwise.neurontin ( gabapentin ) 800 mg po qiddetrol ( tolterodine ) 2 mg po bidnumber of doses required ( approximate ): 3celebrex ( celecoxib ) 200 mg po bidfood/drug interaction instruction take with foodalert overridden: override added on 12/10/02 by :definite allergy ( or sensitivity ) to nsaid'spossible allergy ( or sensitivity ) to nsaid'sdefinite allergy ( or sensitivity ) to nsaid'sreason for override: pt takes regularlylasix ( furosemide ) 40 mg qam; 20 mg qpm po qd 40 mg qam20 mg qpm starting today julyalert overridden: override added on 12/10/02 by :potentially serious interaction: fluoxetine hcl &furosemide reason for override: pt takes regulary; awarealbuterol nebulizer 2.5 mg neb q4halbuterol inhaler 2 puff inh qidatrovent nebulizer ( ipratropium nebulizer )0.5 mg neb qidatrovent inhaler ( ipratropium inhaler ) 2 puff inh qidoscal 500 + d ( calcium carb + d ( 500mg elem c... )1 tab po qiddiet: no restrictionsreturn to work: not applicablefollow up appointment( s ):dr. colar 9/21/02 scheduled ,allergy: aspirin , iron ( ferrous sulfate ) , nsaid'sadmit diagnosis:chf exacerbationprincipal discharge diagnosis ;responsible after study for causing admission )chf exacerbationother diagnosis;conditions , infections , complications , affecting treatment/stayobesity ( obesity ) restrictive lung disease ( restrictive pulmonarydisease ) chf ( congestive heart failure ) fibromyalgia( fibromyalgia ) von willebrand's ( hemophilia ) sleep apnea ( sleepapnea ) iron deficiency anemia ( iron deficiency anemia ) hypoxia( hypoxia ) gerd , s/p tah/bso , pica. ? central hypoventilation syndrome.oa.operations and procedures:other treatments/procedures ( not in o.r. )nonebrief resume of hospital course:44 yo f with complex medical hx including chf secondary to diastolicdysfucnction and obstructive sleep apnea/rld of obesity and vonwillibrand's disease presented to skywoodl medical center with worseningsob and pedal edema and increased o2 requirement to 8l last night frombaseline 4l requirement. she denies f/c/n/v but reports increasedyellow sputum production for the last 1-2 mo. pt denies any dietaryindescretion. she has a history of noncompliance with her medicationsbut reports taking them faithfully for the last month--she brought allof her medications ( several bottles empty , several unopened ). shereports palpitations but reports that she has had this for a lon timeand associates it with her anemia. she also reports cp traveling underl. breast with coughing , deep inspiration.pmh:( 1 ) obesity ( 2 )obstructive sleep apena ( 3 ) centralhypoventilation ( 4 )restrictive lung dz. secondary to obesity , osa ( 5 )fybromylgia/ pain syndrome ( 6 )von willibrand dz. ( 7 )stress incontinence( 8 ) gerd ( 9 ) picaa&p: 44 yo f w/mmp and multiple admissions in the past for volumeoverload presents with likely chf flare ( likely secondary to medicalnoncompliance ).1. cv-chf-jvp 9-10 on admission with cxr demonstrating vascularcongestion , 8l o2 requirement; patient was aggressively diuresed withlasix with o2 requirement returning to 4l baseline. ischemia -- ptw/o h/o mi/high cholesterol/dm. +smoking w/15 packyr smoking. lipidpanel sent and pending on discharge. dobutamine mibi completedshowing moderate size anterior septal wall defect consistent with adiagonal lesion. due to the patient's size , this was a technicallyvery limited study and these results could only be stated with mediumprobability. pt unable to start asa b/c of vwd but is alreadymedically managed with atenolol and lisinopril. will need outpatientfollow up. htn -- controlled on outpatient regimen of atenolol 100mg qd , lisinopril 40 mg qd , amlodipine 10 mg qd with sbp 120-150.2. heme - vwd. h/o iron deficiency. not anemic on this admission.3. pulmonary -- patient respiratory status improved with diuresis withadmission 8l o2 requirement weaned to 3-4l with o2 91-92 which is herbaseline4.4. i/d -- afebrile throughout stay; u/a negative; no evidence of pulmonary infection5. endocrine - tsh checked as possible chf stimulus; pending at timeof discharge.6. psych consult attained. pt with traumatic youth and evidence ofdependant personality. thought to have insight into medical conditionbut lack of faith in medications. poor compliance is by choice. maybenefit from outpatient social work/psychology follow up as outpatientas is somewhat resistant to psychiatry. re. belief that cannot touchmetal w/o pain and question of delusions , patient not thought to bedelusio nal or psychotic.7. patient discharged to home with vna visits twice weekly andtransportation arrainged for future office visits.additional comments: please take oll of your previously prescribed medications. only yourlasix has bee changed: please take 40 mg in the morning and 20 mg inthe evening. please call this week for follow-up appointment to seeyour pcp , dr. mehok , in 3 weeks.discharge condition: stableto do/plan:for vna: please emphasize med compliance ( has been chronicallynoncompliant ). also , focus on cardiopulmonary assess , volume status.please draw electrolytes at first visit next week and inform dr.lunetta of results.no dictated summaryentered by: javers , justin a. , m.d. ( sx532 ) 9/5/02 @ 01:07 pm end of discharge orders